Non-Dystrophic Myotonia Disorder Treatment Market Size, Share, Forecast 2030
The report " Non-Dystrophic Myotonia Disorder Treatment Market by Drug Class (Anti-arrhythmic Class IB Drugs, Carbonic Anhydrase Inhibitors, Third line Antimyotonic Agents, Others), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Global Forecasts to 2030"
The global non-dystrophic myotonia disorder treatment market is projected to reach USD 874.39 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 12.3% during the forecast period 2024-2030.